MARESA MUHLETHALER: Open Payments
NPI 1952629792 · HOPKINSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 47 payments from 11 companies in 2025. Trend: 2023 $1,246 · 2024 $771 · 2025 $784
Food & beverage: $784
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $148 |
| AstraZeneca Pharmaceuticals LP | 1 | $124 |
| Globus Medical, Inc. | 2 | $83 |
| Phathom Pharmaceuticals, Inc. | 12 | $82 |
| Astellas Pharma US Inc | 2 | $76 |
| ABBVIE INC. | 3 | $68 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Vanda Pharmaceuticals Inc. | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 1 | $55 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: CAPLYTA, BREZTRI, Senza, VOQUEZNA, Veozah, VRAYLAR, Auvelity, FANAPT.
Industry payments across KY — which companies pay providers there.
